Showing results (1351-1360 of 1,575) with videos related to

Sort By:
Pageof 158
Clinical Toxicology (Philadelphia, Pa.)|October 31, 2014
Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroupMarc Ghannoum, Christopher Yates, Tais F Galvao, et al.
Microbiologyopen|August 7, 2024
New functions of pirin proteins and a 2-ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicileAndrea M Gough, Anita C Parker, Patricia J O'Bryan, et al.
World Journal of Surgery|June 7, 2023
The Impact of Global Collaboration on the Academic Focus of the West African College of Surgeons: Are Worldwide Efforts Aligning with Local Priorities?Gary S Hoffman, Fatemeh P Parvin-Nejad, Matthew S Linz, et al.
Cancer|May 15, 1987
Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?M J Silverstein, R J Rosser, E D Gierson, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 1, 1997
Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF alpha processingM DiMartino, C Wolff, W High, et al.
Stem Cell Reports|December 19, 2015
Spontaneous ATM Gene Reversion in A-T iPSC to Produce an Isogenic Cell LineLucy Lin, Mavis R Swerdel, Michael P Lazaropoulos, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical PropertiesShams Ul Mahmood, Rama Krishna Boddu, Jeremy Eberhard, et al.
Frontiers in Psychology|September 20, 2021
Goldilocks Principle: Preference for Change in Breast Size in Breast Cancer Reconstruction PatientsKrista M Nicklaus, Thao Bui, Mary Catherine Bordes, et al.
Cell|May 31, 1996
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)H Kiyokawa, R D Kineman, K O Manova-Todorova, et al.
Antimicrobial Agents and Chemotherapy|June 4, 2014
Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pyloriPaul S Hoffman, Alexandra M Bruce, Igor Olekhnovich, et al.
Pageof 158